← Eichor
Condition: Myopia Degenerative Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Myopia Degenerative

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elo
Phase 3 · 1 location(s) · Laboratorios Sophia S.A de C.V. · NCT06389110
Myopia Preventing With Distance-image Screen
NA · 1 location(s) · Beijing Airdoc Technology Co., Ltd. · NCT06088225
Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study
Phase N/A · 5 location(s) · The University of New South Wales · NCT06119243
A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses
NA · 4 location(s) · Biotech Healthcare Holding Gmbh · NCT06839898
MAD Trial: Myopia Atropine Dose
Phase 3 · 20 location(s) · Erasmus Medical Center · NCT05667454
Myopia Control Combined PBM With Myopic Defocus Lens in Children
NA · 1 location(s) · Beijing Airdoc Technology Co., Ltd. · NCT05756959
LED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological Myopia
NA · 1 location(s) · Shanghai Eye Disease Prevention and Treatment Center · NCT07312214
"My Eyes, My Light": Amar Chokh, Amar Alo
Phase N/A · 1 location(s) · Data Yakka, Inc. · NCT07135570
Stem Cell Ophthalmology Treatment Study II
NA · 4 location(s) · MD Stem Cells · NCT03011541
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.